Michael Gallagher
Partner, White & Case LLP
[email protected]
Michael Gallagher is based in White & Case LLP’s New York office, where the pharmaceutical portion of his litigation and counselling practice focuses on antitrust, consumer protection and pricing.
Mr Gallagher has successfully defended a wide range of innovator and generic manufacturer business practices, including: reverse payment (pay-for-delay) patent litigation settlements; pricing and contracting strategies throughout the distribution and payment chain; average-wholesale-price and wholesaleacquisition- cost policies; co-pay assistance programmes; and product innovation strategies (product hopping). He has also successfully challenged anticompetitive supply agreements and filed, on behalf of a biosimilar manufacturer, the first antitrust challenge to exclusionary contracting by the innovator biological manufacturer.
For close to three decades, Mr Gallagher has litigated jury and non-jury cases before federal and state trial and appellate courts throughout the United States.
